Status:
COMPLETED
Combination Diagnostic Strategies in NAFLD
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Non-Alcoholic Fatty Liver Disease
Chronic Liver Disease
Eligibility:
All Genders
18+ years
Brief Summary
Serial combination of biological and elastography tests is accurate to diagnosing advanced fibrosis in non-alcoholic fatty liver disease (NAFLD) patients. In this study, the investigators compared the...
Detailed Description
The investigators retrospectively selected all consecutive adult patients with suspicion of NAFLD who had undergone liver biopsy from November 2011 to July 2019 in 2 French academic centers, Angers an...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- PAtients who underwent a liver biopsy for a suspicion of NAFLD, and liver stiffness evaluation with either Fiborscan and Bidimensional shear wave elastography
- Exclusion criteria:
- Other aetiologies of chronic liver disease
- biopsy length under 10mm
Exclusion
Key Trial Info
Start Date :
November 30 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2019
Estimated Enrollment :
577 Patients enrolled
Trial Details
Trial ID
NCT04384159
Start Date
November 30 2011
End Date
July 31 2019
Last Update
May 12 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.